These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16686780)

  • 1. In vitro tests to predict response to IVIG in sensitized patients.
    Scornik J
    Am J Transplant; 2006 Jun; 6(6):1497. PubMed ID: 16686780
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients.
    Jordan SC; Vo AA; Peng A; Toyoda M; Tyan D
    Am J Transplant; 2006 Mar; 6(3):459-66. PubMed ID: 16468954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful kidney transplantation in highly sensitized patients.
    Zhang W; Chen D; Chen Z; Zeng F; Ming C; Lin Z; Zhou P; Chen G; Chen X
    Front Med; 2011 Mar; 5(1):80-5. PubMed ID: 21681679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulins and kidney transplantation in patients with anti-HLA antibodies.
    Glotz D; Antoine C; Haymann JP; Julia P; Duboust A; Bariéty J
    Adv Nephrol Necker Hosp; 2000; 30():221-33. PubMed ID: 11068645
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
    Jordan SC; Tyan D; Stablein D; McIntosh M; Rose S; Vo A; Toyoda M; Davis C; Shapiro R; Adey D; Milliner D; Graff R; Steiner R; Ciancio G; Sahney S; Light J
    J Am Soc Nephrol; 2004 Dec; 15(12):3256-62. PubMed ID: 15579530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous polyclonal immunoglobulins (IVIG): what use in transplantation?].
    Haymann JP; Glotz D
    Nephrologie; 1999; 20(3):139-43. PubMed ID: 10418003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.
    Matignon M; Pilon C; Commereuc M; Grondin C; Leibler C; Kofman T; Audard V; Cohen J; Canoui-Poitrine F; Grimbert P
    PLoS One; 2017; 12(6):e0178572. PubMed ID: 28654684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitizing the broadly human leukocyte antigen-sensitized patient awaiting deceased donor kidney transplantation.
    Jordan SC; Reinsmoen N; Lai CH; Cao K; Kahwaji J; Peng A; Villicana R; Vo A
    Transplant Proc; 2012 Jan; 44(1):60-1. PubMed ID: 22310579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
    Ibernón M; Gil-Vernet S; Carrera M; Serón D; Moreso F; Bestard O; Cruzado JM; Grinyó JM
    Transplant Proc; 2005 Nov; 37(9):3743-5. PubMed ID: 16386524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
    Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
    Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of antibodies in kidney transplant].
    Ruffoni E; Seveso M; Marson P; Tison T; Cozzi E
    G Ital Nefrol; 2012; 29 Suppl 54():S54-60. PubMed ID: 22388831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular rejection with tacrolimus and potential long-term graft outcome.
    Vanrenterghem Y
    Transplant Proc; 1999 Nov; 31(7A):86S-87S. PubMed ID: 10576054
    [No Abstract]   [Full Text] [Related]  

  • 14. Excellent renal allograft survival in donor-specific antibody transplant patients--role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Dhanda R; Shah Y; Bardapure M; Bhattacharjya S; Sharma AK
    Transplantation; 2009 Aug; 88(3):444. PubMed ID: 19667954
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous Immunoglobulins in the Prevention of Rejection of a Second or Third Kidney Graft.
    Glotz D; Rostaing L; Merville P; Squifflet JP; Lebranchu Y
    Transplant Proc; 2018; 50(1):70-71. PubMed ID: 29407334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications.
    Jordan S; Cunningham-Rundles C; McEwan R
    Am J Transplant; 2003 Jun; 3(6):653-64. PubMed ID: 12780556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose intravenous immunoglobulin therapy for donor-specific antibodies in kidney transplant recipients with acute and chronic graft dysfunction.
    Cooper JE; Gralla J; Klem P; Chan L; Wiseman AC
    Transplantation; 2014 Jun; 97(12):1253-9. PubMed ID: 24937199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
    Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
    Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of high-dose human immune globulin in highly sensitized patients on the kidney transplant waiting list: one center's experience.
    Gozdowska J; Urbanowicz A; Perkowska-Ptasinska A; Michalska K; Chmura A; Szmidt J; Durlik M
    Transplant Proc; 2009 Oct; 41(8):2997-3001. PubMed ID: 19857660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience.
    Jordan SC; Vo AA; Nast CC; Tyan D
    Clin Transpl; 2003; ():193-8. PubMed ID: 15387111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.